A High Resolution/Accurate Mass (HRAM) Data-Dependent MS                         
                        3
                                                  Neutral Loss Screening, Classification, and Relative Quantitation Methodology for Carbonyl Compounds in Saliva

Romel  Dator; Andrea Carra'; Laura A Maertens; Valeria Guidolin; Peter W Villalta; Silvia Balbo

doi:10.1007/s13361-016-1521-y

A High Resolution/Accurate Mass (HRAM) Data-Dependent MS ³ Neutral Loss Screening, Classification, and Relative Quantitation Methodology for Carbonyl Compounds in Saliva

Romel Dator, Andrea Carra', Laura A Maertens, Valeria Guidolin, Peter W Villalta, Silvia Balbo

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Reactive carbonyl compounds (RCCs) are ubiquitous in the environment and are generated endogenously as a result of various physiological and pathological processes. These compounds can react with biological molecules inducing deleterious processes believed to be at the basis of their toxic effects. Several of these compounds are implicated in neurotoxic processes, aging disorders, and cancer. Therefore, a method characterizing exposures to these chemicals will provide insights into how they may influence overall health and contribute to disease pathogenesis. Here, we have developed a high resolution accurate mass (HRAM) screening strategy allowing simultaneous identification and relative quantitation of DNPH-derivatized carbonyls in human biological fluids. The screening strategy involves the diagnostic neutral loss of hydroxyl radical triggering MS ³ fragmentation, which is only observed in positive ionization mode of DNPH-derivatized carbonyls. Unique fragmentation pathways were used to develop a classification scheme for characterizing known and unanticipated/unknown carbonyl compounds present in saliva. Furthermore, a relative quantitation strategy was implemented to assess variations in the levels of carbonyl compounds before and after exposure using deuterated d ₃ -DNPH. This relative quantitation method was tested on human samples before and after exposure to specific amounts of alcohol. The nano-electrospray ionization (nano-ESI) in positive mode afforded excellent sensitivity with detection limits on-column in the high-attomole levels. To the best of our knowledge, this is the first report of a method using HRAM neutral loss screening of carbonyl compounds. In addition, the method allows simultaneous characterization and relative quantitation of DNPH-derivatized compounds using nano-ESI in positive mode. [Figure not available: see fulltext.]

Original language	English (US)
Pages (from-to)	608-618
Number of pages	11
Journal	Journal of the American Society for Mass Spectrometry
Volume	28
Issue number	4
DOIs	https://doi.org/10.1007/s13361-016-1521-y
State	Published - Apr 1 2017

Bibliographical note

Funding Information:
The authors would like to thank the volunteers of the research study "Acetaldehyde-derived DNA adducts for the investigation of alcohol hangover" at the University of Minnesota and Robert Carlson for editorial assistance. This work was supported by NIOSH-funded MCOHS ERC Pilot Research Training Program (OH008434). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official view of the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, or other associated entities. Mass spectrometry was carried out in the Analytical Biochemistry Shared Resource of the Masonic Cancer Center, University of Minnesota, funded in part by Cancer Center Support Grant CA-077598 and S10 RR-024618 (Shared Instrumentation Grant).

Publisher Copyright:
© 2016, American Society for Mass Spectrometry.

Keywords

Aldehydes/carbonyl compounds
DNPH-derivatization
Exposome
High resolution accurate mass data-dependent MS neutral loss screening
Relative quantitation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1007/s13361-016-1521-y

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772964

OpenUrl availability

Full text

Cite this

Dator, R., Carra', A., Maertens, L. A., Guidolin, V., Villalta, P. W., & Balbo, S. (2017). A High Resolution/Accurate Mass (HRAM) Data-Dependent MS ³ Neutral Loss Screening, Classification, and Relative Quantitation Methodology for Carbonyl Compounds in Saliva. Journal of the American Society for Mass Spectrometry, 28(4), 608-618. https://doi.org/10.1007/s13361-016-1521-y

A High Resolution/Accurate Mass (HRAM) Data-Dependent MS ³ Neutral Loss Screening, Classification, and Relative Quantitation Methodology for Carbonyl Compounds in Saliva. / Dator, Romel ; Carra', Andrea; Maertens, Laura A et al.
In: Journal of the American Society for Mass Spectrometry, Vol. 28, No. 4, 01.04.2017, p. 608-618.

Research output: Contribution to journal › Article › peer-review

Dator, R, Carra', A, Maertens, LA, Guidolin, V, Villalta, PW & Balbo, S 2017, 'A High Resolution/Accurate Mass (HRAM) Data-Dependent MS ³ Neutral Loss Screening, Classification, and Relative Quantitation Methodology for Carbonyl Compounds in Saliva', Journal of the American Society for Mass Spectrometry, vol. 28, no. 4, pp. 608-618. https://doi.org/10.1007/s13361-016-1521-y

Dator R, Carra' A, Maertens LA, Guidolin V, Villalta PW , Balbo S. A High Resolution/Accurate Mass (HRAM) Data-Dependent MS ³ Neutral Loss Screening, Classification, and Relative Quantitation Methodology for Carbonyl Compounds in Saliva. Journal of the American Society for Mass Spectrometry. 2017 Apr 1;28(4):608-618. doi: 10.1007/s13361-016-1521-y

Dator, Romel ; Carra', Andrea ; Maertens, Laura A et al. / A High Resolution/Accurate Mass (HRAM) Data-Dependent MS ³ Neutral Loss Screening, Classification, and Relative Quantitation Methodology for Carbonyl Compounds in Saliva. In: Journal of the American Society for Mass Spectrometry. 2017 ; Vol. 28, No. 4. pp. 608-618.

@article{7faaa769f9e44147ba2833f2d574512f,

title = "A High Resolution/Accurate Mass (HRAM) Data-Dependent MS 3 Neutral Loss Screening, Classification, and Relative Quantitation Methodology for Carbonyl Compounds in Saliva",

abstract = " Reactive carbonyl compounds (RCCs) are ubiquitous in the environment and are generated endogenously as a result of various physiological and pathological processes. These compounds can react with biological molecules inducing deleterious processes believed to be at the basis of their toxic effects. Several of these compounds are implicated in neurotoxic processes, aging disorders, and cancer. Therefore, a method characterizing exposures to these chemicals will provide insights into how they may influence overall health and contribute to disease pathogenesis. Here, we have developed a high resolution accurate mass (HRAM) screening strategy allowing simultaneous identification and relative quantitation of DNPH-derivatized carbonyls in human biological fluids. The screening strategy involves the diagnostic neutral loss of hydroxyl radical triggering MS 3 fragmentation, which is only observed in positive ionization mode of DNPH-derivatized carbonyls. Unique fragmentation pathways were used to develop a classification scheme for characterizing known and unanticipated/unknown carbonyl compounds present in saliva. Furthermore, a relative quantitation strategy was implemented to assess variations in the levels of carbonyl compounds before and after exposure using deuterated d 3 -DNPH. This relative quantitation method was tested on human samples before and after exposure to specific amounts of alcohol. The nano-electrospray ionization (nano-ESI) in positive mode afforded excellent sensitivity with detection limits on-column in the high-attomole levels. To the best of our knowledge, this is the first report of a method using HRAM neutral loss screening of carbonyl compounds. In addition, the method allows simultaneous characterization and relative quantitation of DNPH-derivatized compounds using nano-ESI in positive mode. [Figure not available: see fulltext.] ",

keywords = "Aldehydes/carbonyl compounds, DNPH-derivatization, Exposome, High resolution accurate mass data-dependent MS neutral loss screening, Relative quantitation",

author = "Romel Dator and Andrea Carra' and Maertens, {Laura A} and Valeria Guidolin and Villalta, {Peter W} and Silvia Balbo",

note = "Funding Information: The authors would like to thank the volunteers of the research study {"}Acetaldehyde-derived DNA adducts for the investigation of alcohol hangover{"} at the University of Minnesota and Robert Carlson for editorial assistance. This work was supported by NIOSH-funded MCOHS ERC Pilot Research Training Program (OH008434). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official view of the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, or other associated entities. Mass spectrometry was carried out in the Analytical Biochemistry Shared Resource of the Masonic Cancer Center, University of Minnesota, funded in part by Cancer Center Support Grant CA-077598 and S10 RR-024618 (Shared Instrumentation Grant). Publisher Copyright: {\textcopyright} 2016, American Society for Mass Spectrometry.",

year = "2017",

month = apr,

day = "1",

doi = "10.1007/s13361-016-1521-y",

language = "English (US)",

volume = "28",

pages = "608--618",

journal = "Journal of the American Society for Mass Spectrometry",

issn = "1044-0305",

publisher = "Springer New York",

number = "4",

}

TY - JOUR

T1 - A High Resolution/Accurate Mass (HRAM) Data-Dependent MS 3 Neutral Loss Screening, Classification, and Relative Quantitation Methodology for Carbonyl Compounds in Saliva

AU - Dator, Romel

AU - Carra', Andrea

AU - Maertens, Laura A

AU - Guidolin, Valeria

AU - Villalta, Peter W

AU - Balbo, Silvia

N1 - Funding Information: The authors would like to thank the volunteers of the research study "Acetaldehyde-derived DNA adducts for the investigation of alcohol hangover" at the University of Minnesota and Robert Carlson for editorial assistance. This work was supported by NIOSH-funded MCOHS ERC Pilot Research Training Program (OH008434). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official view of the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, or other associated entities. Mass spectrometry was carried out in the Analytical Biochemistry Shared Resource of the Masonic Cancer Center, University of Minnesota, funded in part by Cancer Center Support Grant CA-077598 and S10 RR-024618 (Shared Instrumentation Grant). Publisher Copyright: © 2016, American Society for Mass Spectrometry.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Reactive carbonyl compounds (RCCs) are ubiquitous in the environment and are generated endogenously as a result of various physiological and pathological processes. These compounds can react with biological molecules inducing deleterious processes believed to be at the basis of their toxic effects. Several of these compounds are implicated in neurotoxic processes, aging disorders, and cancer. Therefore, a method characterizing exposures to these chemicals will provide insights into how they may influence overall health and contribute to disease pathogenesis. Here, we have developed a high resolution accurate mass (HRAM) screening strategy allowing simultaneous identification and relative quantitation of DNPH-derivatized carbonyls in human biological fluids. The screening strategy involves the diagnostic neutral loss of hydroxyl radical triggering MS 3 fragmentation, which is only observed in positive ionization mode of DNPH-derivatized carbonyls. Unique fragmentation pathways were used to develop a classification scheme for characterizing known and unanticipated/unknown carbonyl compounds present in saliva. Furthermore, a relative quantitation strategy was implemented to assess variations in the levels of carbonyl compounds before and after exposure using deuterated d 3 -DNPH. This relative quantitation method was tested on human samples before and after exposure to specific amounts of alcohol. The nano-electrospray ionization (nano-ESI) in positive mode afforded excellent sensitivity with detection limits on-column in the high-attomole levels. To the best of our knowledge, this is the first report of a method using HRAM neutral loss screening of carbonyl compounds. In addition, the method allows simultaneous characterization and relative quantitation of DNPH-derivatized compounds using nano-ESI in positive mode. [Figure not available: see fulltext.]

AB - Reactive carbonyl compounds (RCCs) are ubiquitous in the environment and are generated endogenously as a result of various physiological and pathological processes. These compounds can react with biological molecules inducing deleterious processes believed to be at the basis of their toxic effects. Several of these compounds are implicated in neurotoxic processes, aging disorders, and cancer. Therefore, a method characterizing exposures to these chemicals will provide insights into how they may influence overall health and contribute to disease pathogenesis. Here, we have developed a high resolution accurate mass (HRAM) screening strategy allowing simultaneous identification and relative quantitation of DNPH-derivatized carbonyls in human biological fluids. The screening strategy involves the diagnostic neutral loss of hydroxyl radical triggering MS 3 fragmentation, which is only observed in positive ionization mode of DNPH-derivatized carbonyls. Unique fragmentation pathways were used to develop a classification scheme for characterizing known and unanticipated/unknown carbonyl compounds present in saliva. Furthermore, a relative quantitation strategy was implemented to assess variations in the levels of carbonyl compounds before and after exposure using deuterated d 3 -DNPH. This relative quantitation method was tested on human samples before and after exposure to specific amounts of alcohol. The nano-electrospray ionization (nano-ESI) in positive mode afforded excellent sensitivity with detection limits on-column in the high-attomole levels. To the best of our knowledge, this is the first report of a method using HRAM neutral loss screening of carbonyl compounds. In addition, the method allows simultaneous characterization and relative quantitation of DNPH-derivatized compounds using nano-ESI in positive mode. [Figure not available: see fulltext.]

KW - Aldehydes/carbonyl compounds

KW - DNPH-derivatization

KW - Exposome

KW - High resolution accurate mass data-dependent MS neutral loss screening

KW - Relative quantitation

UR - http://www.scopus.com/inward/record.url?scp=85016249669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016249669&partnerID=8YFLogxK

U2 - 10.1007/s13361-016-1521-y

DO - 10.1007/s13361-016-1521-y

M3 - Article

C2 - 27785693

AN - SCOPUS:85016249669

SN - 1044-0305

VL - 28

SP - 608

EP - 618

JO - Journal of the American Society for Mass Spectrometry

JF - Journal of the American Society for Mass Spectrometry

IS - 4

ER -